Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC
by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta
Updated on: September 27,2024
0

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC
by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta
Updated on:September 27,2024
0
